AGREEMENTAmendment No. 2 to Schedule 13g • February 15th, 2022 • Armistice Capital, LLC • Biological products, (no disgnostic substances)
The undersigned agree that this Amendment No. 2 to Schedule 13G dated February 14, 2022 relating to the Common Stock, $0.001 par value, of Voyager Therapeutics, Inc. shall be filed on behalf of the undersigned.
